The morning session of the 2025 National Conference opens: CR Sanjiu and YILING PHARMACEUTICAL enter the arena, negotiations on traditional Chinese medicine varieties begin

According to reporters from the 2025 National Medical Insurance Catalog on-site negotiations and commercial insurance innovative drug catalog price negotiations, the process of the fourth day of the 2025 national negotiations began around 8 a.m. Representatives from pharmaceutical companies such as CR Sanjiu, Jianmin Pharmaceutical, Beijing YILING PHARMACEUTICAL, Eisai, and Kereis Pharmaceutical entered the venue in turn to await negotiations. Representatives from traditional Chinese medicine companies entered in succession, and negotiations for traditional Chinese medicine varieties are expected to begin